Targeted Anticytokine Therapy in Patients With Chronic Heart Failure
Cornell University · The University of Texas Southwestern Medical Center · +6 more institutions
Abstract
BACKGROUND: Studies in experimental models and preliminary clinical experience suggested a possible therapeutic role for the soluble tumor necrosis factor antagonist etanercept in heart failure. METHODS AND RESULTS: Patients with New York Heart Association class II to IV chronic heart failure and a left ventricular ejection fraction
Citation impact
- FWCI
- 33.86
- Percentile
- 100%
- References
- 21
Authors
20- DLDouglas L. MannCorresponding
Cornell University, The University of Texas Southwestern Medical Center
- JJJohn J.V. McMurray
Cornell University, The University of Texas Southwestern Medical Center
- MPMilton Packer
Cornell University, The University of Texas Southwestern Medical Center
- KSKarl Swedberg
Cornell University, The University of Texas Southwestern Medical Center
- JBJeffrey Borer
Cornell University, The University of Texas Southwestern Medical Center
Topics & keywords
- Etanercept
- Medicine
- Heart failure
- Placebo
- Ejection fraction
- Internal medicine
- Clinical trial
- Clinical endpoint
- Good health and well-being